CIK 0001819411
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Gain Therapeutics, Inc.
Sign in to watch- Ticker
- GANX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851726310
- Phone
- +1 301-500-1556
- Business address
- 4800 HAMPDEN LANE, SUITE 200, BETHESDA, MD, 20814
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-15 | Islam Khalid Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-06-24 | Islam Khalid Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2024-08-09 | Islam Khalid Executive Chairman | Purchase | +50,000 | $1.00 | $50K | 50,000 |
| 2024-06-24 | Islam Khalid Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2023-06-23 | Islam Khalid Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2022-09-20 | Islam Khalid Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 |
Page 1 of 1 · 6 trades